Paper81287
Antifibrinolytic therapy of subarachnoid hemorrhage by intrathecal administration of p-aminomethylbenzoic acid.
Heidrich R and 3 others. J Neurol, 1978. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Antifibrinolytic therapy of subarachnoid hemorrhage by intrathecal administration of p-aminomethylbenzoic acid. Papers, record 81287. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/81287
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Antifibrinolytic therapy of subarachnoid hemorrhage by intrathecal administration of p-aminomethylbenzoic acid.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| 4-Aminobenzoic Acid | Major topic |
| Aminobenzoates | Major topic |
| Antifibrinolytic Agents | Major topic |
| Subarachnoid Hemorrhage | Major topic |
| Humans | |
| Injections, Spinal | |
| para-Aminobenzoates |
Source PubMed
References7
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5639737 | Antifibrinolytic therapy for intracranial aneurysms. | J Neurosurg | 1968 | https://conductscience.org/library/papers/5639737 | PubMed |
| 2 | 1198627 | Intracranial aneurysms and subarachnoid hemorrhage. A cooperative study. Antifibrinolytic therapy in recent onset subarachnoid hemorrhage. | Stroke | 1975 | https://conductscience.org/library/papers/1198627 | PubMed |
| 3 | 5026538 | Preoperative management of patients with ruptured intracranial aneurysms. | J Neurosurg | 1972 | https://conductscience.org/library/papers/5026538 | PubMed |
| 4 | 877166 | [Hemostatic processes in aneurysmal hemorrhages]. | Psychiatr Neurol Med Psychol (Leipz) | 1977 | https://conductscience.org/library/papers/877166 | PubMed |
| 5 | 4718188 | The use of antifibrinolytic drugs to prevent early recurrent aneurysmal subarachnoid haemorrhage. | Acta Neurol Scand | 1973 | https://conductscience.org/library/papers/4718188 | PubMed |
| 6 | 4138295 | Letter: E-aminocaproic acid and subarachnoid haemorrhage. | Lancet | 1974 | https://conductscience.org/library/papers/4138295 | PubMed |
| 7 | 878925 | Fibrinolytic activity in the walls of cerebral saccular aneurysms. | Acta Neurochir (Wien) | 1977 | https://conductscience.org/library/papers/878925 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 19374502 | Subarachnoid hemorrhage and the distribution of drugs delivered into the cerebrospinal fluid. Laboratory investigation. | J Neurosurg | 2009 | https://conductscience.org/library/papers/19374502 | PubMed |
| 2407050 | Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study. | Acta Neurochir (Wien) | 1990 | https://conductscience.org/library/papers/2407050 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/81287
GET https://conductscience.org/api/papers/v1/81287/authors